ArticleScientific reports2022

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice.

Humzah Jamshaid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.